ReutersRoche joins race for obesity drugs with $2.7 billion Carmot dealDec 4Ludwig BurgerBy Ludwig Burgermore_vert
Financial TimesRoche to buy Carmot for up to $3.1bn as race for obesity drugs intensifiesDec 4Donato Paolo ManciniBy Donato Paolo Mancinimore_vert
MarketWatchRoche strikes $3.1 billion deal to buy obesity drug maker Carmot TherapeuticsDec 4Louis GossBy Louis Gossmore_vert
GlobeNewswireRoche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets ...Dec 4more_vert
CNBCRoche enters obesity market with Carmot takeover but drugs may not be available until 2030Dec 4Karen GilchristBy Karen Gilchristmore_vert
BloombergRoche to Buy Obesity Drug Maker Carmot for $3.1 BillionDec 4Paula DoeneckeBy Paula Doeneckemore_vert
STATRoche to buy Carmot Therapeutics, developer of obesity drugsDec 4Andrew JosephBy Andrew Josephmore_vert